Hound Partners - XERIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Hound Partners ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$181,000
-82.7%
68,037
-87.3%
0.02%
-83.7%
Q1 2020$1,049,000537,7040.10%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,498,666$42,477,0001.70%
Redmile Group, LLC 2,412,641$41,015,0001.65%
SABBY MANAGEMENT, LLC 202,916$3,450,0000.76%
ArrowMark Colorado Holdings LLC 652,748$11,097,0000.12%
Granahan Investment Management 82,504$1,403,0000.10%
OppenheimerFunds, Inc. 1,000,000$17,000,0000.02%
FEDERATED HERMES, INC. 300,000$5,100,0000.01%
FMR LLC 2,280,968$38,776,0000.01%
Tower Research Capital LLC (TRC) 1,016$17,0000.00%
BlackRock Inc. 645,035$10,966,0000.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders